NOVA CLINICAL RESEARCH, LLC
BRADENTON, FLORIDA

NOVA CLINICAL RESEARCH, LLC is a professional research site committed to excellence in clinical research. As a Florida registered company under the filing number M14000000526, it adheres to established guidelines and regulations. Located on the third floor of the Medical Arts building at Blake Medical Center Campus, the company offers convenience for its operations. Incorporated on January 23, 2014, NOVA operates in Bradenton, within Manatee County, FL. Despite being headquartered in Florida, the home state is listed as Delaware (DE). The business is classified under foreign limited liability company type (FORL) and maintains a mailing address at 2010 59TH STREET WEST, SUITE # 3800, BRADENTON, FL, 34209. Showkat Hossain serves as the Manager. The company remains reachable via phone at (941) 702-6564 or (941) 792-6531 and can be explored further through its website at novaclinicalresearch.com. The last notable corporate activity occurred on March 25, 2019, marked by a Limited Change Amendment. Its most recent annual report was filed on January 5, 2024, for the year 2024. Additionally, NOVA holds a Foreign Entity Identification Number (FEI) of 464490415.

KEY FACTS ABOUT NOVA CLINICAL RESEARCH, LLC

Company name
NOVA CLINICAL RESEARCH, LLC
Status
Active
Filed Number
M14000000526
FEI Number
464490415
Date of Incorporation
January 23, 2014
Age - 12 years
Home State
DE
Company Type
Foreign Limited Liability

CONTACTS

Website
http://novaclinicalresearch.com
Phones
(941) 792-6564
(941) 792-6531

NOVA CLINICAL RESEARCH, LLC NEAR ME

Principal Address
2010 59TH STREET WEST, SUITE # 3800,
BRADENTON,
FL,
34209,
US

See Also

Officers and Directors

The NOVA CLINICAL RESEARCH, LLC managed by the one person from BRADENTON on following positions: Manager

Showkat Hossain

Position
Manager Active
From
BRADENTON, FL





Registered Agent is Showkat Hossain

From
BRADENTON, 34209

Events

March 25, 2019
LC AMENDMENT
March 4, 2014
LC AMENDMENT

Annual Reports

2025
February 9, 2025
2024
January 5, 2024